Laparoscopic cytoreduction after neoadjuvant chemotherapy (LANCE): feasibility phase of a randomized trial

被引:0
|
作者
Rauh-Hain, J. Alejandro [1 ]
Melamed, Alexander [2 ]
Pareja, Rene [3 ]
Sinno, Abdulrahman [4 ]
Mcnally, Leah [5 ]
Horowitz, Neil [6 ]
Iaco, Pierandrea De [7 ]
Michener, Chad [8 ]
May, Taymaa [9 ]
Lonkhuijzen, Luc Van [10 ]
Iniesta, Maria [1 ]
Suki, Tina [1 ]
Yuan, Ying [1 ]
Coleman, Robert [11 ]
Ramirez, Pedro [12 ]
Fagotti, Anna [13 ]
机构
[1] MD Anderson Canc Ctr, Gynecol Oncol & Reprod Med, Houston, TX USA
[2] Massachusetts Gen Hosp, Obstet & Gynecol, Boston, MA USA
[3] Hosp Gen Medellin, Gynecol Oncol, Medellin, Colombia
[4] Univ Miami, Miller Sch Med, Sylvester Comprehens Canc Ctr, Obstet & Gynecol, Miami, FL USA
[5] Duke Univ, Obstet & Gynecol, Durham, NC USA
[6] Dana Farber Canc Ctr, Gynecol Oncol, Boston, MA USA
[7] Univ Bologna, Obstet & Gynecol, Bologna, Italy
[8] Cleveland Clin, Dept Obstet & Gynecol, Cleveland, OH USA
[9] Princess Margaret Canc Ctr, Gynecol Oncol, Toronto, ON, Canada
[10] Univ Amsterdam, Med Ctr, Gynecol Oncol, Amsterdam, Netherlands
[11] US Oncol, Texas Oncol, Houston, TX USA
[12] Methodist Hosp, Obstet & Gynecol, Houston, TX USA
[13] Fdn Policlin A Gemelli, Gynecol Oncol, Rome, Italy
关键词
D O I
10.1136/ijgc-2023-IGCS.14
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
PO014
引用
收藏
页码:A12 / A12
页数:1
相关论文
共 50 条
  • [21] Feasibility, Safety, and Preliminary Efficacy of Exercise During and After Neoadjuvant Rectal Cancer Treatment: A Phase II Randomized Controlled Trial
    Morielli, Andria R.
    Usmani, Nawaid
    Boule, Normand G.
    Severin, Diane
    Tankel, Keith
    Joseph, Kurian
    Nijjar, Tirath
    Fairchild, Alysa
    Courneya, Kerry S.
    CLINICAL COLORECTAL CANCER, 2021, 20 (03) : 216 - 226
  • [22] A Randomized Phase II Trial of Neoadjuvant Chemotherapy Compared with Chemoradiotherapy in Locally Advanced Gastric Adenocarcinoma
    Wang, X.
    Jin, J.
    Zhao, D. B.
    Chi, Y. H. B. L.
    Yang, L.
    Jiang, L.
    Dou, L. Z.
    Tang, Y.
    Li, N.
    Liu, W., Jr.
    Tian, Y. T.
    Zhao, H.
    Che, X.
    Bai, X. F.
    Lu, N.
    Hua, R.
    Fang, H.
    Wang, S. L.
    Song, Y. W.
    Liu, Y.
    Li, Y. X.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2018, 102 (03): : S29 - S30
  • [23] Assessment of Laparoscopic Indocyanine Green Tracer-guided Lymphadenectomy After Neoadjuvant Chemotherapy for Locally Advanced Gastric Cancer A Randomized Controlled Trial
    Huang, Ze-Ning
    Tang, Yi-Hui
    Zhong, Qing
    Li, Ping
    Xie, Jian-Wei
    Wang, Jia-Bin
    Lin, Jian-Xian
    Lu, Jun
    Cao, Long-Long
    Lin, Mi
    Tu, Ru-Hong
    Zheng, Chao-Hui
    Chen, Qi-Yue
    Huang, Chang-Ming
    ANNALS OF SURGERY, 2024, 279 (06) : 923 - 931
  • [24] A randomized controlled phase III trial comparing two chemotherapy regimen and chemoradiotherapy regimen as neoadjuvant
    Kato, Ken
    Ito, Yoshinori
    Daiko, Hiroyuki
    Ozawa, Soji
    Ogata, Takashi
    Hara, Hiroki
    Kojima, Takashi
    Abe, Tetsuya
    Bamba, Takeo
    Watanabe, Masaya
    Kawakubo, Hirofumi
    Shibuya, Yuichi
    Tsubosa, Yasuhiro
    Takegawa, Naoki
    Kajiwara, Takeshi
    Baba, Hideo
    Ueno, Masaki
    Machida, Ryunosuke
    Nakamura, Kenichi
    Kitagawa, Yuko
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (04)
  • [25] A Feasibility Randomized Controlled Trial of Prehabilitation During Neoadjuvant Chemotherapy for Women with Breast Cancer: A Mixed Methods Study
    Priya Brahmbhatt
    Nicole J. Look Hong
    Apishanthi Sriskandarajah
    Nasrin Alavi
    Sarah Selvadurai
    David Berger-Richardson
    Sharon Lemon-Wong
    Joanna Mascarenhas
    Leslie Gibson
    Tracey Rapier
    Elie Isenberg-Grzeda
    Lori J. Bernstein
    Daniel Santa Mina
    Frances C. Wright
    Annals of Surgical Oncology, 2024, 31 : 2261 - 2271
  • [26] A Feasibility Randomized Controlled Trial of Prehabilitation During Neoadjuvant Chemotherapy for Women with Breast Cancer: A Mixed Methods Study
    Brahmbhatt, Priya
    Look Hong, Nicole J.
    Sriskandarajah, Apishanthi
    Alavi, Nasrin
    Selvadurai, Sarah
    Berger-Richardson, David
    Lemon-Wong, Sharon
    Mascarenhas, Joanna
    Gibson, Leslie
    Rapier, Tracey
    Isenberg-Grzeda, Elie
    Bernstein, Lori J.
    Santa Mina, Daniel
    Wright, Frances C.
    ANNALS OF SURGICAL ONCOLOGY, 2024, 31 (04) : 2261 - 2271
  • [27] A Phase II Trial of Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy for Recurrent Adrenocortical Carcinoma
    Hughes, Marybeth S.
    Lo, Winifred M.
    Beresnev, Tatiana
    Merino, Maria
    Shutack, Yvonne
    Ripley, R. Taylor
    Hernandez, Jonathan M.
    Davis, Jeremy L.
    JOURNAL OF SURGICAL RESEARCH, 2018, 232 : 383 - 388
  • [28] Minimally invasive surgery versus laparotomy for interval cytoreduction after neoadjuvant chemotherapy for ovarian cancer
    Mori, K.
    Hoppenot, C. H.
    Helenowski, I.
    Berry, E.
    Lurain, J. R., III
    Neubauer, N. L.
    GYNECOLOGIC ONCOLOGY, 2015, 137 : 128 - 130
  • [29] Comparing a PD-L1 inhibitor plus chemotherapy to chemotherapy alone in neoadjuvant therapy for locally advanced ESCC: a randomized Phase II clinical trial A randomized clinical trial of neoadjuvant therapy for ESCC
    Li, Yong
    Zhou, Aiping
    Liu, Shuoyan
    He, Ming
    Chen, Keneng
    Tian, Ziqiang
    Li, Yin
    Qin, Jianjun
    Wang, Zhen
    Chen, Haiquan
    Tian, Hui
    Yu, Yue
    Qu, Wang
    Xue, Liyan
    He, Shun
    Wang, Shuhang
    Bie, Fenglong
    Bai, Guangyu
    Zhou, Bolun
    Yang, Zhaoyang
    Huang, Huiyao
    Fang, Yan
    Li, Benjamin
    Dai, Xiangrong
    Gao, Shugeng
    He, Jie
    BMC MEDICINE, 2023, 21 (01)
  • [30] PATTERNS OF RECURRENCE AFTER COMPLETE CYTOREDUCTION AND HYPERTHERMIC INTRAPERITONEAL CHEMOTHERAPY IN OVARIAN CANCER PATIENTS WITH NEOADJUVANT CHEMOTHERAPY OR UPFRONT SURGERY
    Barakat, Philipp
    Sardi, Armando
    Nikiforchin, Andrei
    King, Mary Caitlin
    Zuniga, Luis Felipe Falla
    Lopez-Ramirez, Felipe
    Nieroda, Carol
    Baron, Ekaterina
    Gushchin, Vadim
    Diaz-Montes, Teresa
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2022, 32 : A130 - A131